HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Induction of protective antitumor immunity through attenuation of ERAAP function.

Abstract
The endoplasmic reticulum aminopeptidase associated with Ag processing, ERAAP, plays an important role in the trimming of antigenic peptides for presentation at the cell surface complexed with MHC class I molecules. Tumors express varying levels of ERAAP, highlighting a possible mechanism of immune-evasion through alteration of the peptide repertoire. Using the CT26 tumor model, we investigated the effects of ERAAP modulation on peptide presentation and the use of ERAAP inhibition as an antitumor therapy. We show that generation of the cross-protective tumor Ag GSW11 in the colorectal carcinoma CT26 is increased when ERAAP expression is reduced. BALB/c mice with reduced ERAAP expression challenged with CT26 induced protective immunity that was mediated by CD8(+) T cells. This antitumor immunity also protected mice when rechallenged with wild-type CT26 tumor; strong CD8(+) T cell responses to GSW11 were observed, despite its presentation being considerably lower. Furthermore, boosting the tumor immunogenicity through inhibition of ERAAP function with the small molecule inhibitor leucinethiol in vitro, or in established tumors in vivo, abrogated tumor growth and prolonged survival. Thus, our results highlight the promising possibility of using modulation of ERAAP to generate protective antitumor responses as a strategy for cancer immunotherapy.
AuthorsEdward James, Ian Bailey, Gessa Sugiyarto, Tim Elliott
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 190 Issue 11 Pg. 5839-46 (Jun 01 2013) ISSN: 1550-6606 [Electronic] United States
PMID23610143 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, Neoplasm
  • Enzyme Inhibitors
  • Leucyl Aminopeptidase
  • puromycin-insensitive leucyl-specific aminopeptidase
Topics
  • Animals
  • Antigen Presentation
  • Antigens, Neoplasm (immunology, metabolism)
  • CD8-Positive T-Lymphocytes (immunology, metabolism)
  • Cell Line, Tumor
  • Enzyme Inhibitors (pharmacology)
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Gene Silencing
  • Humans
  • Leucyl Aminopeptidase (antagonists & inhibitors, genetics, metabolism)
  • Mice
  • Neoplasms (genetics, immunology, metabolism, mortality)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: